Galderma
Generated by Meeveem AI
"The pure play dermatology leader advancing skin health through science based innovation."
About Galderma
Galderma develops and supplies products across injectable aesthetics, dermatological skincare and therapeutic dermatology. Founded in 1981 and headquartered in Zug, Switzerland, it works with healthcare professionals to address skin needs from everyday skincare to prescription treatment and medical aesthetics. Its portfolio includes brands such as Cetaphil, Restylane and Nemluvio.
The group reported 7,676 employees in 2025 and operates research and development centres and four manufacturing sites worldwide. Its education, training and medical awareness activities reached over 290,000 healthcare professionals during 2025. UK and Ireland teams, based in London, support distribution across all three business areas and work directly with healthcare providers.
Development and progression
Galderma describes career development through stretch assignments, moves between functions, formal learning, coaching and mentoring. Its annual Development Month focused on coaching in 2025, supporting development across science, commercial, operations and support teams.
Working with healthcare professionals
UK and Ireland teams work with clinicians who use Galderma products and take part in national dermatology and aesthetics congresses. These relationships sit alongside the group’s wider work in research, product supply and medical education across skin health.
7676
Team Members
1981
Founded
Pharma
Sector
Hybrid
Work Environment